1388P Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program

标题
1388P Poziotinib in advanced NSCLC with EGFR or HER2 exon 20 insertion mutation: Initial results from a single site expanded access program
作者
关键词
-
出版物
ANNALS OF ONCOLOGY
Volume 31, Issue -, Pages S882
出版商
Elsevier BV
发表日期
2020-09-22
DOI
10.1016/j.annonc.2020.08.1702

向作者/读者发起求助以获取更多资源

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started